IPHA

Innate Pharma SA is a pioneering biotechnology firm headquartered in Marseille, France, specializing in the development of innovative therapeutic antibodies for oncology. The company boasts a strong pipeline of proprietary immune-oncology candidates designed to improve treatment outcomes for cancer patients worldwide. With a strategic emphasis on monoclonal antibodies and immune-mediated therapies, Innate Pharma is well-positioned to capitalize on the growing demand for cutting-edge cancer treatments, enhancing its competitive stature and growth prospects in the dynamic biotech landscape.